
Vogbetic 0.3 MD Tablet
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Voglibose (0.3mg)
Overview Vogbetic 0.3 MD Tablet
Diabetol 0.3mg tablets are prescribed for managing type 2 diabetes. They help regulate post-prandial hyperglycemia (high blood sugar after meals), employed when dietary adjustments and other similar medications prove insufficient. Diabetol 0.3mg should be administered immediately before each meal; dosage and frequency are determined by your physician for optimal blood glucose control. Discontinue use only under medical supervision; abrupt cessation may elevate blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial while using Diabetol 0.3mg. Commonly reported side effects include abdominal discomfort, bloating, appetite changes, bowel irregularities (constipation or diarrhea). Report persistent or bothersome side effects to your doctor. While Diabetol 0.3mg alone doesn't cause hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with pure glucose; sucrose is ineffective in this context. Inform your doctor of any liver or kidney issues prior to commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals must consult their doctor before use. Disclose all medications to your physician to ensure safe use. Limit alcohol consumption while taking Diabetol 0.3mg to minimize the hypoglycemia risk.
Uses of Vogbetic 0.3 MD Tablet
Managing type 2 diabetes
Major Benefits of Vogbetic 0.3 MD Tablet:
Administer Vogbetic 0.3 MD Tablet as prescribed by your physician, adhering to both dosage and treatment length. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing it immediately. This medication should be taken on an empty stomach.
Common Side effects of Vogbetic 0.3 MD Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogbetic 0.3 MD Tablet:
Administer this medication precisely as directed by your physician regarding dosage and treatment length. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Vogbetic 0.3 MD Tablets should be ingested on an empty stomach.
How Vogbetic 0.3 MD Tablet works:
Vogbetic 0.3 MD tablets are used to manage diabetes by blocking the action of intestinal enzymes that digest complex carbohydrates. This action reduces postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Vogbetic 0.3 MD Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vogbetic 0.3 MD Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Using Vogbetic 0.3 MD Tablet while breastfeeding appears to pose minimal risk. Available data from humans indicates negligible infant harm.
DrivingSAFE
Driving ability is typically unaffected by Vogbetic 0.3 MD Tablet.
KidneyCAUTION
Exercise caution when administering Vogbetic 0.3 MD Tablet to patients exhibiting severe renal impairment. Dosage modification for Vogbetic 0.3 MD Tablet may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vogbetic 0.3 MD Tablets. Dosage modification of Vogbetic 0.3 MD Tablets may be necessary. Physician consultation is advised.
What if you forget to take Vogbetic 0.3 MD Tablet :
Omit any missed Vogbetic 0.3 MD Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogbetic 0.3 MD Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavior Class | Alpha-glucosidase inhibitors |
